How does tracking affect monitoring progress
For now, however, curiosity should be balanced with caution
Since obesity is a chronic illness that can lead to type 2 diabetes, cardiovascular disease, certain cancers, and sleep disorders, the FDA responded by approving the use of semaglutide in increased dosages for treating obesity and overweight individuals with certain weight-related diseases
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity About the Author Craig Primack, MD, FACP, MFOMA is the Founder and Managing Member of Scottsdale Weight Loss Center and a leading physician in medical weight loss
Costantini, C., Bellet, M
Many patients achieve meaningful results using relatively low or moderate doses, particularly when combining medication with: Nutrition improvements Strength training Sleep optimization Consistency Lifestyle changes Higher doses are not always necessary for successful weight loss